S. Kimura, Y. Nakamura, N. Kobayashi, K. Shiroguchi, E. Kawakami, M. Mutoh, H. Iwanaga, T. Yamada, M. Hisamoto, M. Nakamura, N. Udagawa, S. Sato, T. Kaisho, T. Iwanaga, K. Hase. 2020. Osteoprotegerin-dependent M-cell self-regulation balances gut infection and immunity. Nat Commun. 11:234.
Y. Nakamura, H. Mimura, J. Kunisawa, Y. Furusawa, D. Takahashi, Y. Fujimura, T. Kaisho, H. Kiyono, K. Hase. 2020. Microfold Cell-Dependent Antigen Transport Alleviates Infectious Colitis by Inducing Antigen-Specific Cellular Immunity. Mucosal Immunol. 13:679-690.
Y. Mizumoto, H. Hemmi, M. Katsuda, M. Miyazawa, Y. Kitahata, A. Miyamoto, M. Nakamori, T. Ojima, K. Matsuda, M. Nakamura, K. Hayata, Y. Fukuda-Ohta, M. Sugiyama, T. Ohta, T. Orimo, S. Okura, I. Sasaki, K. Tamada, H. Yamaue, T. Kaisho. 2020. Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockade. Br J Cancer 122:1185-1193.
R. Miyazaki, H. Saiga, T. Kato, T. Bakoshi, R. Senba, A. Shintani, M. Suzuki, K. Takao, I. Sasaki, A. Iizuka, M. Sugiyama, N. Iwami, Y. Fukuda-Ohta, H. Hemmi, T. Tanaka, M. Miyake, T. Kaisho, K. Hoshino. 2020. The mechanism of action of Spi-B in the transcriptional activation of the interferon-α4 gene. Biochem Biophys Res Commun. 525:477-482.
D. Ashour, P. Arampatzi, V. Pavlovic, K. U Förstner, T. Kaisho, A. Beilhack, F. Erhard, M. B Lutz. 2020. IL-12 From Endogenous cDC1, and Not Vaccine DC, Is Required for Th1 Induction, JCI Insight 5:135143.
Y. Kato, T. M. Steiner, H. Park, R. O. Hitchcock, A. Zaid, J. Liang Hor, S. Devi, G. M. Davey, D. Vremec, K. M. Tullett, P. S. Tan, F. Ahmet, S. N. Mueller, S. Alonso, D. M. Tarlinton, H. L. Ploegh, T. Kaisho, L. Beattie, J. H. Manton, D. Fernandez-Ruiz, K. Shortman, M. H. Lahoud, W. R. Heath and I. Caminschi. 2020. Display of native antigen on cDC1 that have spatial access to both T and B cells underlies efficient humoral vaccination. J Immunol 205:1842-1856.
A. Jodo, A. Shibazaki, A. Onuma, T. Kaisho, and T. Tanaka. 2020. PDLIM7 synergizes with PDLIM2 and p62/Sqstm1 to inhibit inflammatory signaling by promoting degradation of the p65 Subunit of NF-κB. Front Immunol. 11:1559.
